Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is a phase 2 study (the second phase in testing a new drug or drug combination) to see how useful adding investigational drug cediranib to olaparib after disease progression on olaparib alone in patients with ovarian cancer.
Critère d'inclusion
- Ovarian Cancer